Predicting Outcome in Follicular Lymphoma by Using Interactive Gene Pairs
暂无分享,去创建一个
L. Greller | H. Feilotter | R. Somogyi | D. LeBrun | R. Sidhu | P. Farmer | T. Baetz | K. Harrison | Hong Guo | Cheryl Foster
[1] Roland Somogyi,et al. Prediction of Graft-Versus-Host Disease in Humans by Donor Gene-Expression Profiling , 2007, PLoS medicine.
[2] Jochen H M Prehn,et al. Systems analysis of effector caspase activation and its control by X‐linked inhibitor of apoptosis protein , 2006, The EMBO journal.
[3] T. Reiman,et al. Pathway-specific apoptotic gene expression profiling in chronic lymphocytic leukemia and follicular lymphoma , 2006, Modern Pathology.
[4] N. Sevenet,et al. Ability of breast cancer cell lines to stimulate bone resorbing activity of mature osteoclasts correlates with an anti-apoptotic effect mediated by macrophage colony stimulating factor , 2006, Apoptosis.
[5] D. States,et al. Colony-stimulating factor-1 requires PI3-kinase-mediated metabolism for proliferation and survival in myeloid cells , 2006, Cell Death and Differentiation.
[6] J. Balsinde,et al. Overexpression of Cytosolic Group IVA Phospholipase A2 Protects Cells from Ca2+-dependent Death* , 2006, Journal of Biological Chemistry.
[7] Y. Qiu,et al. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs , 2006, Oncogene.
[8] N. Sneige,et al. The feasibility of gene expression profiling generated in fine‐needle aspiration specimens from patients with follicular lymphoma and diffuse large B‐cell lymphoma , 2005, Cancer.
[9] J. Briones,et al. Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] M. Murakami,et al. Cellular Distribution, Post-translational Modification, and Tumorigenic Potential of Human Group III Secreted Phospholipase A2* , 2005, Journal of Biological Chemistry.
[11] P. Solal-Céligny. Prognosis of follicular lymphomas. , 2005, Clinical lymphoma.
[12] M. Hilgarth,et al. Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2 , 2005, Leukemia.
[13] L. Greller,et al. Transcription-Based Prediction of Response to IFNβ Using Supervised Computational Methods , 2004, PLoS biology.
[14] L. Staudt,et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.
[15] J. Delabie,et al. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. , 2004, The Journal of molecular diagnostics : JMD.
[16] J. Shelhamer,et al. Transforming Growth Factor-β (TGF-β) Activates Cytosolic Phospholipase A2α (cPLA2α)-mediated Prostaglandin E2 (PGE)2/EP1 and Peroxisome Proliferator-activated Receptor-γ (PPAR-γ)/Smad Signaling Pathways in Human Liver Cancer Cells , 2004, Journal of Biological Chemistry.
[17] A. López-Guillermo,et al. Follicular lymphoma international prognostic index. , 2004, Blood.
[18] B. Nathwani,et al. Use of the World Health Organization (WHO) Classification of Non-Hodgkin's Lymphoma in Mumbai, India: A Review of 200 Consecutive Cases by a Panel of Five Expert Hematopathologists , 2004, Leukemia & lymphoma.
[19] Z. Zhai,et al. RIP5 is a RIP-homologous inducer of cell death. , 2004, Biochemical and biophysical research communications.
[20] E. Bruyneel,et al. Trefoil factor family (TFF) peptides and cancer progression , 2004, Peptides.
[21] H. Stein,et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. , 2004, Blood.
[22] Mattias Höglund,et al. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas , 2004, Genes, chromosomes & cancer.
[23] J. Miguel,et al. Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation , 2004, Leukemia.
[24] C. S. Swindle,et al. Activated Notch2 Potentiates CD8 Lineage Maturation and Promotes the Selective Development of B1 B Cells , 2003, Molecular and Cellular Biology.
[25] R. Gascoyne,et al. Multicolour fluorescence in situ hybridization analysis of t(14;18)‐positive follicular lymphoma and correlation with gene expression data and clinical outcome , 2003, British journal of haematology.
[26] I. Lossos,et al. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. , 2003, Seminars in cancer biology.
[27] Zhaosheng Lin,et al. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Aizawa,et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. , 2003, Immunity.
[29] Ash A. Alizadeh,et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. , 2003, Blood.
[30] D. Edwards,et al. Statistical Analysis of Gene Expression Microarray Data , 2003 .
[31] Terry Speed,et al. Design and analysis of comparative microarray experiments , 2003 .
[32] H. Shih,et al. Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferation , 2002, Oncogene.
[33] F. Jardin,et al. Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease? , 2002, Leukemia.
[34] K. Elenitoba-Johnson,et al. Microarray analysis of B-cell lymphoma cell lines with the t(14;18). , 2002, The Journal of molecular diagnostics : JMD.
[35] David Botstein,et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. Rosenwald,et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. , 2002, Blood.
[37] G. Morgan,et al. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells. , 2002, Blood.
[38] M. Mareel,et al. Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase‐ and thromboxane A2 receptor‐dependent signaling pathways , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] E. Devilard,et al. Correlation between apoptosis macroarray gene expression profiling and histopathological lymph node lesions , 2001, Molecular pathology : MP.
[40] F. Jardin,et al. Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3′ BCL2 breakpoints and evidence of a new cluster , 2000, Leukemia.
[41] D. Taupin,et al. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Mak,et al. Interleukin 13 Is Secreted by and Stimulates the Growth of Hodgkin and Reed-Sternberg Cells , 1999, The Journal of experimental medicine.
[43] E. White,et al. Btf, a Novel Death-Promoting Transcriptional Repressor That Interacts with Bcl-2-Related Proteins , 1999, Molecular and Cellular Biology.
[44] J C Reed,et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. , 1997, Blood.
[45] B. Nathwani,et al. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project , 1997 .
[46] A. López-Guillermo,et al. Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution. , 1994, Leukemia & lymphoma.
[47] D. Longo,et al. p53 mutation is associated with progression in follicular lymphomas. , 1993, Blood.
[48] Jing Lin,et al. Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells , 2005, Clinical & Experimental Metastasis.
[49] Peter Joosten,et al. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. , 2005, Blood.
[50] James Olen Armitage,et al. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. , 1997, Blood.